Lv3
220 积分 2024-08-09 加入
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
2天前
已完结
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
29天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
1个月前
已完结
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib in Clinical Practice in the United States
1个月前
已完结
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
1个月前
已完结
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory
1个月前
已完结
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis
3个月前
已完结
Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment
3个月前
已完结
Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study
4个月前
已完结
皖公网安备34019202002308
